<DOC>
	<DOCNO>NCT01025934</DOCNO>
	<brief_summary>The purpose study evaluate role , safety effectiveness Intravitreal Bevacizumab injection adjunct vitrectomy management severe proliferative diabetic retinopathy .</brief_summary>
	<brief_title>Intravitreal Bevacizumab Surgical Treatment Severe Proliferative Diabetic Retinopathy</brief_title>
	<detailed_description />
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>vitreous haemorrhage tractional retinal detachment active proliferative diabetic retinopathy . neovascular glaucoma cataract combine traction rhegmatogenous RD</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>